Laboratory Centrifuge Market

Laboratory Centrifuge Market Outlook (2025 to 2035)

The global laboratory centrifuge market is expected to reach USD 2,304 million by 2035, up from USD 1,726 million in 2024. During the forecast period (2025 to 2035), the industry is projected to expand at a CAGR of 2.7%.

Over the span of next ten years, the industry is poised to grow 1.3X with an absolute dollar opportunity of USD 538.8 million. This robust growth trajectory underscores a highly favorable market outlook, signaling significant potential for investment, innovation, and strategic expansion across the sector.

Laboratory centrifuges are essential diagnostic and research instruments used to separate substances of different densities within a liquid, typically through high-speed rotational force. Commonly employed in clinical laboratories, pharmaceutical research, biotechnology, and academic settings, they enable processes such as blood separation, DNA extraction, and protein purification. Their precision, speed, and adaptability make them vital for enhancing accuracy and efficiency across diverse scientific and medical applications.

Metric	Value
Industry Size (2025E)	USD 1,765 million
Industry Value (2035F)	USD 2,304 million
CAGR (2025 to 2035)	2.7%

What are the drivers of the Laboratory Centrifuge market?

The laboratory centrifuge market is experiencing robust growth driven by increasing demand across biotechnology, pharmaceutical, and clinical research sectors. As precision medicine, genomics, and cell biology continue to advance, laboratories require efficient and reliable sample preparation equipment. Centrifuges are essential tools in a range of applications including blood separation, DNA extraction, protein purification, and cell culture processing, fueling market expansion.

One of the major drivers is global investment in healthcare infrastructure and life sciences R&D increasing. There is increasing private and public investment in pharma R&D and diagnostic labs, especially in developing economies. It is creating a good demand for flexible, high-speed centrifuges that can perform intricate procedures in research and diagnosis.

Technological innovation is also improving the efficiency and availability of new centrifuges. The reality that smaller, automated devices with increased safety, touch screen-based operating interfaces, and programmable user software are increasingly becoming available is making them easier to use and accessible for utilization in most laboratory facilities. Energy efficiency and lower noise are also emerging as leading differentiating features.

Pharma pipeline expansion and clinical trials on the growth worldwide are the primary demand drivers for high-throughput processing. In addition, the growth in personalized medicines and biopharmaceuticals is increasing the use of laboratory centrifuges as the core part of lab activities, generating long-term market demand.

What are the regional trends of the Laboratory Centrifuge market?

North America leads the laboratory centrifuge market, driven by advanced healthcare systems, strong funding for life sciences research, and widespread adoption of cutting-edge diagnostic technologies. The United States plays a key role, with significant demand coming from clinical laboratories, academic institutions, and pharmaceutical companies. There is well-developed regulatory infrastructure that ensures quality and safety and thus gaining more steam for adoption of next-generation centrifuge technology.

Europe is showing steady growth, driven by intense focus on correct diagnosis and clinical research. The U.K., France, and Germany are investing in laboratory modernization and in the development of high-throughput testing capacity. Strong EU regulation and enforcement of high equipment efficiency and safety standards also drive product innovation and quality standards.

Maximum growth is a result of being encouraged by the Asia-Pacific nations, rising investments in healthcare, expanding biotech markets, and the increasing number of diagnostic laboratories. Incentives by the Chinese and Indian governments make the up-take in medical education a driving force in healthcare advancement. The dynamism of Japan and South Korea together contributes to healthcare advancement in terms of leading technology capabilities and high automation requirements for equipment in laboratories.

Brazil, Mexican Latin American economies are growing with rising healthcare, laboratory expansion. Middle East, Africa also are experiencing high growth, led by Gulf nations, as a result of research center, hospital investment fueling demand for efficient, stable centrifuge systems to be utilized in therapy, diagnostics.

What are the challenges and restraining factors of the Laboratory Centrifuge market?

The laboratory centrifuge market faces several challenges that could hinder its growth trajectory. One of the primary issues is the high cost of advanced centrifuge systems. Initial investment, combined with recurring maintenance and calibration costs, can be a deterrent for smaller laboratories or facilities operating with limited budgets.

Compliance with regulations is another major challenge. Companies must adhere to strict international quality norms for equipment safety, contamination protection, and operational precision. This can distract from product development and increase certification costs, especially when entering new geographies with varying regulatory environments.

Global supply chain inefficiencies and procurement issues have an impact on the market. The procurement process for essential parts or the shipping of finished equipment may result in disruption to the schedules of laboratory installation and updating. High-technology centrifuge systems require high time investment, particularly in the low-tech-capacity regions.

Shifts in the Laboratory Centrifuge Market from 2020 to 2024 and Future Trends 2025 to 2035

The laboratory centrifuge market witnessed consistent growth between 2020 and 2024, driven by expanding research activities, biopharmaceutical development, and diagnostic innovations across clinical laboratories and academic institutions.

The growing reliance on precision equipment for molecular biology, cell culture separation, and blood processing sustained the demand for high-speed and ultracentrifuge units. With the rising prominence of personalized medicine and gene sequencing, laboratories increasingly prioritized centrifuge models that offer higher efficiency, rotor flexibility, and precise temperature control.

During this period, regulatory standards concerning laboratory safety and calibration became more stringent, prompting manufacturers to improve design compliance and equipment reliability. The integration of automation and smart monitoring features enhanced workflow efficiency and minimized manual handling.

Additionally, the rise of biotech startups and increased public-private healthcare investments in emerging markets contributed to a more globally distributed demand. Overall, the historical phase was characterized by modernization, stronger safety compliance, and continuous innovation in separation technologies.

Market Shift	2020 to 2024
Regulatory Landscape	Tighter calibration standards and enhanced lab safety protocols.
Technological Advancements	Improved rotor designs, programmable centrifuges, and integrated cooling systems.
Industry-Specific Demand	Driven by healthcare, academic research, and clinical diagnostics.
Sustainability & Circular Economy	Initial focus on energy efficiency and waste reduction.
Production & Supply Chain	Dependence on global suppliers for critical components.
Market Growth Drivers	Growth in biotech funding, lab automation trends, and clinical testing.

Market Shift	2025 to 2035
Regulatory Landscape	Global harmonization of lab equipment standards and carbon-neutral design mandates.
Technological Advancements	AI-integrated diagnostics, real-time performance tracking, and energy-efficient systems.
Industry-Specific Demand	Expanding into regenerative medicine, forensic science, and decentralized diagnostic labs.
Sustainability & Circular Economy	Widespread use of recyclable components, modular repair systems, and green certifications.
Production & Supply Chain	Shift to regionalized manufacturing, additive production methods, and smart inventory control.
Market Growth Drivers	Rising demand for point-of-care testing, genomic research, and sustainability integration.

Future Outlook (2025 to 2035)

From 2025 to 2035, the laboratory centrifuge market is expected to evolve rapidly through digitalization, eco-conscious engineering, and tailored application designs. A major shift will come from AI-driven systems that can optimize spin cycles in real time, adjust for sample variability, and alert for maintenance, minimizing human intervention. Energy consumption will become a key differentiator, with manufacturers introducing low-power, high-efficiency models to align with global carbon reduction goals.

There will be notable diversification in use cases, with centrifuges becoming integral in emerging fields like tissue engineering, space-based biomedical research, and advanced point-of-care systems in remote locations. The push for modularity and long-life components will also gain momentum, allowing facilities to upgrade specific parts instead of replacing full systems, supporting circular economy goals.

Emerging regions will present growth frontiers, particularly in Asia-Pacific and Africa, where public health infrastructure is expanding. Companies that localize production, offer cloud-based support, and ensure compliance with evolving global standards will capture a larger share of this increasingly specialized and sustainability-focused market.

Country-Wise Insights

Country	CAGR (2025 to 2035)
United States	1.6%
Germany	3.9%
China	3.1%

United States (U.S.)

Increasing applications in molecular biology, clinical diagnostics, and pharmaceutical research are some of the key factors driving the market for United States. Good healthcare infrastructure, coupled with world-class teaching and research equipment, forms a solid foundation for long-term product development and market penetration. With rising rates of infectious and chronic diseases, demand for effective diagnostic machinery has increased, and centrifuges are leading the charge.

Government funding and grants from the NIH and CDC, and public and private investments are encouraging the adoption of advanced, automated centrifuge machines. Internet of Things -based monitoring systems and local players are integrating intelligent diagnostics technologies into laboratory equipment.

Safety, accuracy, and regulation standardization systems are also influencing the market growth. The country has a well-established biotech start-up culture, contract research organizations, and diagnostic laboratories that keep the United States at the forefront of interest for the innovation and utilization of laboratory equipment.

Germany

Germany represents one of the most mature and innovation-driven markets for laboratory centrifuges in Europe. The country’s strong foundation in life sciences research, engineering, and medical technology serves as a key driver for consistent demand for high-performance centrifuge products.

Market opportunities exist across pharmaceutical R&D, biotechnology, academic research, and diagnostics. Government support for scientific research, along with robust public-private collaboration, further stimulates innovation in laboratory equipment.

German producers put high importance on energy-saving engineering, minimal process, and automation to maximum use and laboratory effectiveness. German product quality and EU norm conformity guarantee performance and global competitiveness. Special centrifuge applications such as molecular biology and clinical trials are increasingly accepted in Germany as well. Increased laboratory automation, and Germany will be able to maintain the leadership role in product development and high-tech centrifuge exports.

China

China's market for laboratory centrifuges is growing significantly with healthcare reforms, enhanced research activity, and domestic market growth in biotechnology. Growing pharma manufacturing investments, clinical diagnostics, and academic R&D are major drivers of growth. Government emphasis on indigenous equipment manufacturing and domestic innovation strategic development drives development and installation of new centrifuge systems.

Urbanization in megacities encourages hospital and diagnostic laboratory growth, and with it, the demand for high-efficiency, automated, and miniaturized equipment. Local Chinese companies are rapidly adopting high-end features such as touch panels, programmable functions, and remote diagnostics to meet the demands of contemporary labs.

Growing national interest in genomics and personalized medicine also increases centrifuge usage. Aside from encouraging government policies, penetration by e-commerce channels, and competitively priced, China is evolving as a leader in the worldwide market for lab equipment, continuously developing its local as well as export market.

Category-Wise Analysis

Multipurpose Centrifuges - By Product Type

Multipurpose centrifuges are experiencing robust market growth due to their widespread use across clinical, research, and industrial laboratories. Their ability to accommodate various sample volumes and tube sizes makes them an essential component of high-throughput systems. As the demand for more efficient and flexible laboratory equipment rises, multipurpose centrifuges are increasingly becoming the preferred choice in diagnostics, life sciences, and the pharmaceutical industry.

The major growth drivers include the rising demand for clinical diagnostics, an increased emphasis on precision medicine, and the expansion of molecular biology research. Technological advancements such as brushless motors, touchscreen user interfaces, and auto-balancing systems are enhancing both performance and user convenience.

These centrifuges offer high versatility, supporting both refrigerated and non-refrigerated applications. As laboratories worldwide upgrade their equipment with more advanced solutions, multi-purpose centrifuges are poised to remain at the forefront of market growth.

Biotechnology & Pharmaceutical Companies - By Application

Biotechnology and pharmaceutical companies represent a flourishing application segment for laboratory centrifuges. They depend heavily on centrifugation technologies to purify proteins, recover nucleic acids, and separate cells. Rising worldwide biologics growth, gene therapy, and targeted therapy have encouraged demand for accurate high-speed centrifuges.

Long-term investments in oncology and infectious disease drug R&D are driving equipment replacement and new installations in biotech laboratories. Regulatory requirements of standards such as FDA and EMA also make it possible to apply high-quality centrifuges that meet stringent quality and safety levels.

With more drug production, particularly vaccines and monoclonal antibodies, there will also be a corresponding greater demand for high-capacity efficient centrifuges. More spending on research across the world and growing Asia-Pacific biotech hubs will contribute more to this segment.

Pharmaceutical & Biotechnology Companies - By End User

Pharmaceutical and biotechnology companies are becoming major end users of the market for laboratory centrifuge because they utilize centrifugation on a large scale for manufacturing and research. Pharmaceutical and biotech companies need reproducible and consistent separation of biological products, an essential requirement for drug development, quality testing, and bulk biologic manufacture.

Increased need for vaccines, cell therapy, and biosimilars globally is propelling the use of centrifuges in this market. Increasing regulatory demands and need for process standardization have necessitated the use of high-quality, programmable centrifuges that ensure compliance and reproducibility.

As pharma companies develop R&D capacity and automate their laboratories, floor-standing as well as benchtop model demand continues to increase. Regions such as the Asia-Pacific, Europe, and North America are seeing significant investment in biotech facilities that will drive long-term growth among such end customers.

Competitive Analysis

Key players in the Laboratory Centrifuge Market include Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Kubota Corporation, Danaher Corporation, Andreas Hettich GmbH & Co. KG, QIAGEN, HERMLE Labortechnik GmbH, Koki Holdings Co., Ltd, Eppendorf AG, and Beckman Coulter, Inc.

This market is driven by growing demand for high-throughput sample processing in clinical diagnostics, biotechnology, and pharmaceutical research. There is growing need for accuracy separation, R&D spend acceleration, and scaling-up of bio-banking and genomics programs that are driving competition fully.

Product differentiation is being created by technological advancements such as automated centrifuging systems, temperature control equipment, and benchtop miniaturization. Sustainability, energy-efficient design, sound reduction, and user experience are top concerns for corporations. Corporations have made sustainability a point of emphasis with sustainable material, recyclable components, and energy standards compliance internationally.

Market Share Analysis by Company

Company Name	Estimated Market Share (%), 2024
Top 5 Players	~55-65%
Tier II Players	~20-25%
Other Players	~10-25%

Key Company Offerings and Activities

Company Name	Key Offerings/Activities
Thermo Fisher Scientific Inc.	Offers a wide range of general-purpose, clinical, and microcentrifuges. Focuses on automated and temperature-controlled systems.
Becton, Dickinson and Company	Supplies centrifuges for blood collection and diagnostics. Emphasizes sterility and regulatory compliance in healthcare labs.
Kubota Corporation	Specializes in compact, high-speed centrifuges for lab and industrial applications. Focuses on durability and low maintenance.
Danaher Corporation	Through subsidiaries (e.g., Beckman Coulter), delivers innovative, automated centrifuge systems for diagnostics and life sciences.
Andreas Hettich GmbH & Co. KG	Provides versatile benchtop and floor-standing centrifuges. Known for modular design and customizable configurations.
QIAGEN	Integrates centrifuge solutions with sample prep kits. Targets molecular diagnostics and genomic applications.
HERMLE Labortechnik GmbH	Manufactures precision lab centrifuges with quiet operation and compact designs. Focuses on user-friendly interfaces.

Thermo Fisher Scientific Inc.

Thermo Fisher Scientific is a worldwide centrifuge market leader with a wide variety of microcentrifuges, high-speed, and floor-standing high-capacity systems. The products support very wide ranges of applications across clinical diagnostics, drug development, cell culture, and bioprocessing. Features of digital programmability, remote control, and automation are the key selling features by the company to optimize lab workflow efficiency and reproducibility.

Thermo Fisher's emphasis on low-power product design and low-noise operations complements sustainability targets and laboratory safety standards. By significant R&D spend and international manufacturing presence, the company maintains its entries into early new markets as well as strengthening of its intelligent lab ecosystem by way of cloud-enabled and IoT-ready products.

Danaher Corporation / Beckman Coulter, Inc.

Beckman Coulter, a prominent subsidiary of Danaher Corporation, delivers state-of-the-art centrifugation technologies with a strong emphasis on high-throughput performance, reliability, and clinical relevance. Its product lines feature ultracentrifuges, general-purpose centrifuges, and fully automated systems integrated with data analytics and LIS (Laboratory Information System) compatibility.

Leveraging Danaher’s Kaizen-based continuous improvement culture, Beckman Coulter accelerates innovation cycles and operational excellence. The company invests heavily in digital integration, enabling real-time monitoring and data traceability, which are vital in regulated laboratory environments. With strategic acquisitions and partnerships, Beckman Coulter is enhancing its portfolio to address complex workflows in genomics, proteomics, and infectious disease research.

Eppendorf AG

Eppendorf is a high-performance manufacturer of bench centrifuges with accuracy, ease of use by the operator, and efficient dimension. Serving academia, pharma, and biotech markets foremost, Eppendorf provides adaptable centrifugation products emphasizing rotor interchangeability, quiet operation, and ergonomically designed interfaces.

Touchscreens, programmable profiles, and automatic imbalance detection are common in Eppendorf centrifuges. As the sustainability market leader, Eppendorf integrates recyclable components and energy-saving innovations into its centrifuges while ensuring maximum compatibility with automated laboratory platforms. The company also offers customized customer support and training services, ensuring user confidence and extending equipment life.

QIAGEN

QIAGEN incorporates centrifugation within its end-to-end molecular diagnostics and sample preparation processes, and hence a fundamental enabler of genomics and clinical research. Its centrifuge solutions are usually supplied with proprietary spin-column and magnetic bead kits for rapid DNA, RNA, and protein purification. T

he firm is dedicated to compliance with ISO and FDA, and therefore it is ready for regulated environments and for diagnostic laboratories. Leading the way in infectious disease testing, oncology, and forensic science, QIAGEN is dedicated to high throughput, prevention of contamination, and low hands-on time. Its focus on system integration and automation readiness enable high reproducibility in multi-sample applications. Global customer care and online education also contribute to its customer-focused system.

Andreas Hettich GmbH & Co. KG

Hettich is renowned for its precision-engineered centrifuges that blend German craftsmanship with modular flexibility. Offering tabletop, refrigerated, and floor-standing models, Hettich serves clinical laboratories, blood banks, universities, and industrial QC labs. The company’s innovation lies in customizable rotor systems, ergonomic design, and silent operation-ideal for busy lab environments.

Hettich products are designed for long service life with minimal maintenance and support a wide range of test tubes, microplates, and custom containers. As part of its sustainability initiative, Hettich integrates energy-efficient motors, recyclable materials, and a robust remanufacturing program. Global expansion is supported by a reliable distribution and service network, ensuring fast, localized support for technical and regulatory needs.

Recent Development

• In November 2023, Haier Biomedical introduced a new range of benchtop high-speed refrigerated centrifuges, enhancing laboratory efficiency and safety. These compact units feature rapid acceleration, precise temperature control, and user-friendly digital interfaces, optimizing sample processing across research and clinical applications.

Fact.MR has provided detailed information about the price points of key manufacturers of Laboratory Centrifuge Market positioned across regions, sales growth, production capacity, and speculative technological expansion, in the recently published report.

Segmentation of Laboratory Centrifuge Market

• By Product Type :

  • Multipurpose Centrifuges
  • Micro-centrifuges
  • Ultra-centrifuges
  • Others

• By Application :

  • Biotechnology & Pharmaceutical Companies
  • Academic & Research Institutes
  • Hospitals
  • Diagnostics
  • Others

• By End User :

  • Clinical Laboratories
  • Diagnostic Centers
  • Academic Institutions
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Others

• By Region :

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa